Antibe Therapeutics Inc. announced that Jonathan Ross Goodman has resigned from the company's Board of Directors, effective February 28, 2015.
Antibe Therapeutics Inc.
Equities
ATE
CA0370255097
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |